You have 9 free searches left this month | for more free features.

Multiple ascending doses

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Alzheimer's Disease Trial (CS6253 Solution for Injection, Placebo)

Not yet recruiting
  • Alzheimer's Disease
  • CS6253 Solution for Injection
  • Placebo
  • (no location specified)
Jul 20, 2023

Healthy Volunteers Trial in Copenhagen (AP31969, Placebo)

Not yet recruiting
  • Healthy Volunteers
  • Copenhagen, Denmark
    Acesion Pharma
Sep 27, 2023

Hepatitis B, Chronic Trial in Jilin (AHB-137 injection, Placebo)

Recruiting
  • Hepatitis B, Chronic
  • AHB-137 injection
  • Placebo
  • Jilin, China
    The First Hospital of Jilin University
Nov 2, 2023

Healthy Volunteers Trial in Anaheim (GSBR-1290, Placebo)

Recruiting
  • Healthy Volunteers
  • Anaheim, California
    ACT
May 30, 2023

Hyperlipemia Trial in Beijing (RBD7022, Placebo)

Recruiting
  • Hyperlipemia
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Jun 12, 2023

Infectious Diseases, Bacterial Infections Trial in Adelaide (BWC0977, Placebo)

Not yet recruiting
  • Infectious Diseases
  • Bacterial Infections
  • Adelaide, South Australia, Australia
    CMAX Clinical Research
Jul 12, 2023

Healthy Participants Trial in Glendale, Brooklyn (AZD4144 Part A, AZD4144 Part B, Placebo Part A)

Not yet recruiting
  • Healthy Participants
  • AZD4144 Part A
  • +3 more
  • Glendale, California
  • +1 more
Nov 3, 2023

Healthy Trial in Kistarcsa (XEN-101, Placebo)

Recruiting
  • Healthy
  • Kistarcsa, Hungary
    CRU Hungary - Early Phase Unit
Dec 27, 2022

Healthy Volunteers Trial (RBD4059, Placebo)

Not yet recruiting
  • Healthy Volunteers
  • (no location specified)
Dec 7, 2022

Bladder Cancer Trial in Melbourne (APL-1202 and APL-1501 (Single ascending dose), APL-1202 and APL-1501 (Multiple Ascending

Not yet recruiting
  • Bladder Cancer
  • APL-1202 and APL-1501 (Single ascending dose)
  • APL-1202 and APL-1501 (Multiple Ascending dose)
  • Melbourne, Victoria, Australia
    Nucleus Network Pty Ltd
Sep 11, 2023

Paroxysmal Nocturnal Hemoglobinuria Trial in Changsha (MY008211A tablets, MY008211A tablets matched )

Active, not recruiting
  • Paroxysmal Nocturnal Hemoglobinuria
  • MY008211A tablets
  • MY008211A tablets matched placebo
  • Changsha, Hunan, China
    The Third Hospital of Changsha
Apr 13, 2023

Healthy Volunteers Trial in Miami, Baltimore (GSBR-1290 (Capsule/Tablet), GSBR-1290, Placebo)

Recruiting
  • Healthy Volunteers
  • GSBR-1290 (Capsule/Tablet)
  • +3 more
  • Miami, Florida
  • +2 more
Nov 14, 2023

Healthy Subjects Trial (TLC-6740, Placebo)

Not yet recruiting
  • Healthy Subjects
  • (no location specified)
Apr 19, 2023

Pharmacokinetics Trial (WCK 2349 Oral, Placebo Oral)

Completed
  • Pharmacokinetics
  • WCK 2349 Oral
  • Placebo Oral
  • (no location specified)
Nov 28, 2022

Healthy Volunteers Trial (ARGX-119, Placebo)

Not yet recruiting
  • Healthy Volunteers
  • ARGX-119
  • Placebo
  • (no location specified)
Jan 2, 2023

Idiopathic Pulmonary Fibrosis Trial in Brooklyn (AZD5055, Placebo)

Recruiting
  • Idiopathic Pulmonary Fibrosis
  • Brooklyn, Maryland
    Research Site
Dec 22, 2022

Health Volunteer Trial (RBD5044, Placebo)

Not yet recruiting
  • Health Volunteer
  • (no location specified)
Sep 13, 2022

Healthy Volunteers Trial in Austin (IW-3300, Placebo)

Completed
  • Healthy Volunteers
  • Austin, Texas
    PPD
Sep 15, 2022

Disease Caused by Severe Acute Respiratory Syndrome Coronavirus 2 (Disorder) Trial in Los Angeles (MBS-COV, Placebo)

Recruiting
  • Disease Caused by Severe Acute Respiratory Syndrome Coronavirus 2 (Disorder)
  • Los Angeles, California
    Phase I Unit
Jan 10, 2023

Healthy Participants Trial in Glendale (AZD2389, Placebo)

Not yet recruiting
  • Healthy Participants
  • Glendale, California
    Research Site
Nov 14, 2023

Bioavailability Trial in Austin (WCK 771 IV Infusion, Placebo IV Infusion)

Completed
  • Bioavailability
  • WCK 771 IV Infusion
  • Placebo IV Infusion
  • Austin, Texas
    PPD Phase I Clinic, 7551 Metro Center Drive, Suite 200
Nov 28, 2022

Healthy Trial in Hangzhou (HSK36273, Placebo, Heparin sodium injection)

Completed
  • Healthy
  • Hangzhou, Zhejiang, China
    the Second Affiliated Hospital Zhejiang University School of Med
Feb 14, 2023

Parkinson Disease Trial in Nottingham (NM-101, Placebo)

Not yet recruiting
  • Parkinson Disease
  • Nottingham, United Kingdom
    Quotient Sciences
Mar 16, 2023

Healthy Volunteers Trial in Nedlands (VG290131)

Recruiting
  • Healthy Volunteers
  • Nedlands, Western Australia, Australia
    Linear Clinical Research Ltd
Oct 17, 2023

MDD Trial in Dallas (Drug: CVL-354, Drug: Placebo)

Active, not recruiting
  • Major Depressive Disorder
  • Drug: CVL-354
  • Drug: Placebo
  • Dallas, Texas
    Labcorp Drug Development
Jan 18, 2023